Steven Schutzer from Rutgers New Jersey Medical School is leading a team assessing new vaccine strategies for Lyme disease, including a hybrid approach that can deliver a one-two punch to the microbe that causes the disease and its tick carrier. Learn more.
Recent Posts
- DNA test says it can predict opioid addiction risk. Skeptics aren’t so sure.
- Transfer Scholars Initiative prepares N.J. community college students to thrive at selective four-year schools.
- Scientists May Have Discovered Reason for Long COVID Brain Fog—Here’s Why It Matters.
- Are You at Risk for Addiction?
- NJ health inequities are focus of Rutgers symposium.